Characterization of cytoplasmic secretory granules (PSG), in prostatic epithelium and their transformation-induced loss in dysplasia and adenocarcinoma

Human Pathology

Volumn 29, Issue 12, 1998, Pages 1488-1494

  Cohen, Ronald J ^a   McNeal, John E ^b   Edgar, Stephen G ^b   Robertson, Terry ^b   Dawkins, Hugh J S ^b  

^a PATHWEST LABORATORY MEDICINE   (Australia)

^b NONE

Author keywords

Clear cytoplasm; Granules; Prostate; Protease secretion; Secretory

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; FORMALDEHYDE; GLUTARALDEHYDE; LIPID; PROSTATE SPECIFIC ANTIGEN;

APICAL MEMBRANE; ARTICLE; CELL TRANSFORMATION; CELL VACUOLE; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; ELECTRON MICROSCOPY; EPITHELIUM DYSPLASIA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEEDLE BIOPSY; PROSTATE ADENOCARCINOMA; PROSTATE EPITHELIUM; SECRETORY CELL; SECRETORY GRANULE; TISSUE FIXATION;

EID: 0031673750     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(98)90020-X     Document Type: Article

References (17)

1. McNeal JE: Prostate, in Sternberg SS (ed): Histology for Pathologists (ed 2). Chapter 42. Philadelphia, PA, Raven Press, 1997, pp 997-1017
2. Epstein JI: Prostate Biopsy Interpretation (ed 2). Philadelphia, PA, Lippincott-Raven, 1995, pp 1-12, 87-133
3. Epstein JI: Diagnostic criteria of limited adenocarcinoma of the prostate on needle biopsy. HUM PATHOL 26:223-229, 1995
4. Gleason DF: The Veterans Administration Co-Operative Urological Research Group: Histological grading and clinical staging of prostatic carcinoma, in Tannenbaum M (ed): Urological Pathology. Philadelphia, PA, Lea & Febinger, 1977, pp 171-197
5. McNeal JE, Redwine EA, Freiha FS, et al: Zonal distribution of prostatic adenocarcinoma: Correlation with histologic pattern and direction of spread. Am J Surg Pathol 12:897-906, 1988
6. Brandes D: Lesions of the prostat, in Hill G (ed): Uropathology. New York, NY, Churchill Livingstone, 1989
7. Cina SJ, Epstein JI: Adenocarcinoma of the prostate with atrophic features. Am J Surg Pathol 21:289-295, 1997
8. de Vries CR, McNealJE, Bensch K: The prostatic epithelial cell in dysplasia: An ultrastructural perspective. Prostate 21:209-221, 1992
9. Bass DA, Lewis JC, Szejda P, et al: Activation of lysosomal acid phosphatase of eosinophil leukocytes. Lab Invest 44:403-409, 1981
10. Egesten A, Calafat J, Weller PF, et al: Localization of granule protein in human eosinophil bone marrow progenitors. Int Arch Allergy Imunol 114:130-138, 1997
11. Cohen RJ, Verhaart MJS, Taylor LF: Intracytoplasmic inclusions in benign prostatic epithelium. Arch Pathol Lab Med 118:1030-1031, 1994
12. Grey E, Edgar SG, Cohen RJ: Immunohistochemical detection of PSA antigen using a monoclonal antibody and polyclonal serum: A quantitative assessment using image analysis. Br J Urol 78:104-108, 1996
13. Wolff JM, Borchers H, Effert PJ, et al: Free-to-total prostate-specific-antigen serum concentrations in patients with prostate cancer and benign prostatic hyperplasia. Br J Urol 78:409-413, 1996
14. Brody I, Ronquist G, Gottfries A: Ultrastructural localisation of the prostasome: An organelle in human seminal plasma. Upsala J Med Sci 88:63-80, 1983
15. Nilsson BO, Jin M, Ronquist G: Immunolocalization of prostasomes in the human prostate. Upsala J Med Sci 101:149-158, 1996
16. Epstein JI: Adenosis (atypical adenomatous hyperplasia): Histopathology and relationship to carcinoma. Pathol Res Prac 191:888-898, 1995
17. Gaudin PB, Epstein JI: Adenosis of the prostate: Histologic features in needle biopsy specimens. Am J Surg Pathol 19:737-747, 1995